SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-437144
Filing Date
2013-11-12
Accepted
2013-11-12 08:46:09
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d621569d10q.htm 10-Q 278300
2 EX-31.1 d621569dex311.htm EX-31.1 8162
3 EX-31.2 d621569dex312.htm EX-31.2 8225
4 EX-32.1 d621569dex321.htm EX-32.1 2967
5 EX-32.2 d621569dex322.htm EX-32.2 3030
  Complete submission text file 0001193125-13-437144.txt   2503285

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT appa-20130930.xml EX-101.INS 309555
7 XBRL TAXONOMY EXTENSION SCHEMA appa-20130930.xsd EX-101.SCH 26635
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appa-20130930_cal.xml EX-101.CAL 18788
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appa-20130930_def.xml EX-101.DEF 121135
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE appa-20130930_lab.xml EX-101.LAB 206493
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appa-20130930_pre.xml EX-101.PRE 122259
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 131207180
SIC: 2834 Pharmaceutical Preparations